| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/09/2008 | US7422763 Acid controlled induced viscosity fiber system and uses thereof |
| 09/09/2008 | US7422755 Vaccine against Haemophilus influenzae type a, Haemophilus influenzae type b, Staphylococcus aureus, and Staphylococcus epidermidis; glycoconjugate of cell wall polysaccharide from Bacillus pumilus Sh 18 |
| 09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
| 09/09/2008 | US7422739 Anti-CD20 antibodies |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | CA2460865C Quinoline derivatives as neuropeptide y antagonists |
| 09/09/2008 | CA2409069C Hydrogel composition for transdermal drug delivery |
| 09/09/2008 | CA2359357C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 09/09/2008 | CA2336712C Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 09/09/2008 | CA2332389C Liposomal preparations for the application of antiseptic agents to the interior of the body |
| 09/09/2008 | CA2303901C Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation |
| 09/09/2008 | CA2124677C Immunopotentiatory agents and physiologically acceptable salts thereof |
| 09/04/2008 | WO2008106621A1 Taxane analogs for the treatment of brain cancer |
| 09/04/2008 | WO2008106168A1 Combination of imidazo [1,5-a] pyrazinyl derivatives with an agent that inhibits serine phosphorylation of irs1 for use in the treatment of cancer |
| 09/04/2008 | WO2008106167A1 Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases |
| 09/04/2008 | WO2008105442A1 Sulfonamide derivative |
| 09/04/2008 | WO2008105386A1 Rexinoid compound having alkoxy group |
| 09/04/2008 | WO2008105340A1 Liquid nutritional food and method of producing the same |
| 09/04/2008 | WO2008104975A2 Combination therapy, composition and methods for the treatment of cardiovascular disorders |
| 09/04/2008 | WO2008104737A1 Improved medicinal compositions comprising buprenorphine and naloxone |
| 09/04/2008 | WO2008104736A1 Improved medicinal compositions comprising buprenorphine and nalmefene |
| 09/04/2008 | WO2008104735A1 Improved medicinal compositions comprising buprenorphine and naltrexone |
| 09/04/2008 | WO2008104084A1 Linoleoyl-containing phospholipids and methods for their use |
| 09/04/2008 | WO2008079727A3 Compositions comprising an pan-alpha-2 receptor agonist and an anticonvulsant for treating chronic pain |
| 09/04/2008 | WO2008077772A3 Combination of a retinoid and a platinum anticancer agent |
| 09/04/2008 | WO2008057503A3 Compositions including triciribine and taxanes and methods of use thereof |
| 09/04/2008 | WO2008000513A3 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 09/04/2008 | WO2007144195A3 Pharmaceutical composition with synergistic anticonvulsant effect |
| 09/04/2008 | US20080214681 Taste reducing compositions and related methods |
| 09/04/2008 | US20080214670 Therapeutic Malonic Acid/Acetic Acid C60 Tri-Adducts of Buckminsterfullerene and Methods Related Thereto |
| 09/04/2008 | US20080214665 Novel Approach to Anti-Microbial Host Defense with Molecular Shields with Lipoxin Compounds |
| 09/04/2008 | US20080214662 Methods for the treatment of dementia based on apo e genotype |
| 09/04/2008 | US20080214652 Methods of treating hyperlipidemia |
| 09/04/2008 | US20080214643 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/04/2008 | US20080214640 3'-{[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid or a salt; treatment of thrombocytopenia; may be coadministered with a colony stimulating factor, cytokine, chemokine, or an interleukin or cytokine receptor agonist or antagonist |
| 09/04/2008 | US20080214626 Methods for prevention and treatment of diseases causes by hypertension |
| 09/04/2008 | US20080214608 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics |
| 09/04/2008 | US20080214575 Piperidine derivatives useful as ccr5 antagonists |
| 09/04/2008 | US20080214478 Small Peptides And Methods For Inhibiting The Infiltration Of Eosinophils Into Airways |
| 09/04/2008 | US20080214477 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
| 09/04/2008 | US20080214476 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 09/04/2008 | US20080214475 Small Peptides And Methods For Inhibiting The Mucous Release Into Airways |
| 09/04/2008 | US20080214474 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease |
| 09/04/2008 | US20080214473 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; treatment and prevention of respiratory system disorders; antiinflammatory agents; immunotherapy |
| 09/04/2008 | US20080214472 Small Peptides And Methods For Treatment Of Arthritis |
| 09/04/2008 | US20080214471 Method for inhibition of viral infection |
| 09/04/2008 | US20080213889 Increasing oocyte maturation via treating oocyte in vitro with gonadotropin hormone and hydrolase inhibitor; treating fertility disorders |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213776 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same |
| 09/04/2008 | US20080213411 administering an effective amount of a soybean Kunitz trypsin inhibitor to a mammal; no side effects |
| 09/04/2008 | US20080213400 Combinations of Chromium with Antidiabetics for Glucose Metabolism Disorders |
| 09/04/2008 | US20080213397 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 09/04/2008 | US20080213393 Solid dosage forms; using polyoxyethylene glycol binder; antacids; antidepressants; blood pressure medications; calcium channel blockers; calcium supplements; chemotherapy medications; cold medicines; antihistamines; maintaining or promoting the elimination of feces in the bowel |
| 09/04/2008 | US20080213378 Atorvastatin; lovastatin; a keto analog of mevinolin; pravastatin; simvastatin; velostatin; fluindostatin; cetyl pyridinium, polymer, biopolymer surface stabilizers; suspensions, gels, aerosols, ointments, creams, controlled release; oral, pulmonary, rectal, opthalmic; improved pharmacokinetic profiles |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213314 Combined dna vaccine and biological modifiers for cancer therapy |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213298 Herbal Therapy for the Treatment of Asthma |
| 09/04/2008 | US20080213288 Glucagon-like peptides (GLP-1); for treatment/prevention of diabetes or autoimmune diseases |
| 09/04/2008 | US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 09/04/2008 | US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A |
| 09/04/2008 | US20080213259 Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30L |
| 09/04/2008 | US20080213257 Using cytokine antagonist to treat and prevent rheumatoid arthritis and inflammatory bowel diseases |
| 09/04/2008 | US20080213238 Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair |
| 09/04/2008 | US20080213234 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/04/2008 | US20080213232 Radial Glial Cells Promote Nerve Regeneration and Functional Recovery Following Spinal Cord Injury |
| 09/04/2008 | US20080213227 Using animal progenitor cell culture to propagate organ tissues; tissue engineering; tissue repair; regenerative medicine; treating cell proliferative, arthritic, autoimmune, skin and inflammatory disorders |
| 09/04/2008 | US20080213222 Expression vector comprising nucleotide sequences coding factor IX for treatment of blood disorders |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | US20080213213 Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione |
| 09/04/2008 | US20080213202 Composition For Improving Skin Lipid Barrier Function |
| 09/04/2008 | DE102007011105A1 Mineralcorticoid receptor antagonist for producing drug for permanent treatment of endometriosis, comprises spironolactone, eplerenone and drospirenone |
| 09/04/2008 | CA2679263A1 Sulfonamide compound |
| 09/04/2008 | CA2678675A1 Improved medicinal compositions comprising buprenorphine and naloxone |
| 09/04/2008 | CA2678568A1 Improved medicinal compositions comprising buprenorphine and nalmefene |
| 09/04/2008 | CA2678481A1 Improved medicinal compositions comprising buprenorphine and naltrexone |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964851A1 Treatment of micro-organism infection |
| 09/03/2008 | EP1964575A1 Pharmaceutical comprising ppar agonist |
| 09/03/2008 | EP1964574A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 09/03/2008 | EP1964563A1 Pharmaceutical compositions containing calcium antagonist substances combined with platelet aggregation inhibiting agents for use in systemic arterial hypertension and for the prevention of ischemic vascular events |
| 09/03/2008 | EP1964561A1 Inhibitors of IMPDH enzyme |
| 09/03/2008 | EP1964550A1 Glucocorticoid-nitrooxyderivative compositions |
| 09/03/2008 | EP1962906A2 Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
| 09/03/2008 | EP1962903A1 Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or fltl antagonist for treating cancer |
| 09/03/2008 | EP1962848A2 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases |
| 09/03/2008 | EP1962845A2 Pharmaceutical composition containing donepezil hydrochloride, tablets produced therefrom and method for producing the same |
| 09/03/2008 | EP1962843A2 Use of parp-1 inhibitors |
| 09/03/2008 | EP1962833A2 Photoactivatable antimicrobial agents |
| 09/03/2008 | EP1962832A2 Combinations of a qualene synthase inhibitor and a hmg-coa reductase inhibitor for treating hyperlipidemia |
| 09/03/2008 | EP1962589A2 Synergistic combinations of norketamine and opioid analgesics |
| 09/03/2008 | EP1909835A4 Methods and compositions for treating female infertility using clomiphene |
| 09/03/2008 | EP1587789B1 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 09/03/2008 | EP1545516B1 Topical formulation comprising at least 10% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 09/03/2008 | EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses |
| 09/03/2008 | EP1415667B1 Pancreatic juice secretion regulators comprising lpa receptor controller |
| 09/03/2008 | EP1389094B1 Delivery of sedative-hypnotics trough an inhalation route |
| 09/03/2008 | EP1385551B1 Antineoplastic combinations comprising cci-779 (rapamycin derivative) together with gemcitabine or fluorouracil |
| 09/03/2008 | EP1339398B1 Treatment of motor fluctuations with 5-hydroxytryptamine 1a receptor activity enhancing compounds |